Molecular Pathologist
About The Position
Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time. Available Openings: Monday-Friday, Chicago Based Tuesday-Saturday, Remote Responsibilities: Evaluate NGS sequencing results Conduct pathology review, including IHC for both research and clinical specimens Participate in clinical report review and delivery Collaborate with a multi-disciplinary team focused on answering key biological questions Work to establish and maintain CLIA/CAP compliance in a novel field Preferred Qualifications: MD with a current medical license and board-certified in Anatomic Pathology and/or Clinical Pathology, with board certification or eligibility in Molecular Genetic Pathology Clinical experience with next-generation sequencing interpretation Detailed knowledge and experience in oncology, cancer immunotherapy, medical immunology and clinical research, preferred Excellent managerial, organizational, reporting and communication skills Experience working in a regulated clinical laboratory environment (CLIA/CAP/NYSDOH/QSR) Experience ensuring compliance of a clinical laboratory to regulatory standards Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives. We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.
Nice To Haves
- MD with a current medical license and board-certified in Anatomic Pathology and/or Clinical Pathology, with board certification or eligibility in Molecular Genetic Pathology
- Clinical experience with next-generation sequencing interpretation
- Detailed knowledge and experience in oncology, cancer immunotherapy, medical immunology and clinical research, preferred
- Excellent managerial, organizational, reporting and communication skills
- Experience working in a regulated clinical laboratory environment (CLIA/CAP/NYSDOH/QSR)
- Experience ensuring compliance of a clinical laboratory to regulatory standards
Responsibilities
- Evaluate NGS sequencing results
- Conduct pathology review, including IHC for both research and clinical specimens
- Participate in clinical report review and delivery
- Collaborate with a multi-disciplinary team focused on answering key biological questions
- Work to establish and maintain CLIA/CAP compliance in a novel field
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Education Level
No Education Listed
Number of Employees
1,001-5,000 employees
